- call +1-201-465-4211
- email sales@mrinsights.biz
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.
Scope of the Report:
This report focuses on the Diabetes Drug Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Diabetes Drug Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach 10000 million US$ in 2023, from 10000 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Glucagon-like peptide-1 (GLP-1) agonist
Dipeptidyl-peptidase-4 (DPP-4) inhibitors
Sodium glucose co-transporter 2 (SGLT2) inhibitors
Insulin
Others
Market Segment by Applications, can be divided into
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Impaired Glucose Tolerance and Impaired Fasting Glycaemia
There are 15 Chapters to deeply display the global Diabetes Drug Therapy market.
Chapter 1, to describe Diabetes Drug Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Diabetes Drug Therapy, with sales, revenue, and price of Diabetes Drug Therapy, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Diabetes Drug Therapy, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Diabetes Drug Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Diabetes Drug Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Diabetes Drug Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Glucagon-like peptide-1 (GLP-1) agonist
1.2.2 Dipeptidyl-peptidase-4 (DPP-4) inhibitors
1.2.3 Sodium glucose co-transporter 2 (SGLT2) inhibitors
1.2.4 Insulin
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Type 1 Diabetes
1.3.2 Type 2 Diabetes
1.3.3 Gestational Diabetes
1.3.4 Impaired Glucose Tolerance and Impaired Fasting Glycaemia
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Diabetes Drug Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mannkind Corporation
2.2.1 Business Overview
2.2.2 Diabetes Drug Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mannkind Corporation Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol Myers Squibb
2.3.1 Business Overview
2.3.2 Diabetes Drug Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol Myers Squibb Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Medtronic
2.4.1 Business Overview
2.4.2 Diabetes Drug Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Medtronic Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Diabetes Drug Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly and Company
2.6.1 Business Overview
2.6.2 Diabetes Drug Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly and Company Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 GlaxoSmithKline
2.7.1 Business Overview
2.7.2 Diabetes Drug Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GlaxoSmithKline Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Diabetes Drug Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novo Nordisk
2.9.1 Business Overview
2.9.2 Diabetes Drug Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novo Nordisk Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis International AG
2.10.1 Business Overview
2.10.2 Diabetes Drug Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis International AG Diabetes Drug Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Diabetes Drug Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Diabetes Drug Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Diabetes Drug Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Diabetes Drug Therapy Manufacturer Market Share in 2017
3.3.2 Top 6 Diabetes Drug Therapy Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Diabetes Drug Therapy Market Analysis by Regions
4.1 Global Diabetes Drug Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Diabetes Drug Therapy Sales and Market Share by Regions (2013-2018)
4.1.2 Global Diabetes Drug Therapy Revenue and Market Share by Regions (2013-2018)
4.2 North America Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
4.3 Europe Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
4.5 South America Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
5 North America Diabetes Drug Therapy by Countries
5.1 North America Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
5.1.1 North America Diabetes Drug Therapy Sales and Market Share by Countries (2013-2018)
5.1.2 North America Diabetes Drug Therapy Revenue and Market Share by Countries (2013-2018)
5.2 United States Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
5.3 Canada Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
5.4 Mexico Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6 Europe Diabetes Drug Therapy by Countries
6.1 Europe Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
6.1.1 Europe Diabetes Drug Therapy Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Diabetes Drug Therapy Revenue and Market Share by Countries (2013-2018)
6.2 Germany Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6.3 UK Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6.4 France Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6.5 Russia Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
6.6 Italy Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7 Asia-Pacific Diabetes Drug Therapy by Countries
7.1 Asia-Pacific Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Diabetes Drug Therapy Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Diabetes Drug Therapy Revenue and Market Share by Countries (2013-2018)
7.2 China Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7.3 Japan Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7.4 Korea Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7.5 India Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
8 South America Diabetes Drug Therapy by Countries
8.1 South America Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America Diabetes Drug Therapy Sales and Market Share by Countries (2013-2018)
8.1.2 South America Diabetes Drug Therapy Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
8.3 Argentina Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
8.4 Colombia Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9 Middle East and Africa Diabetes Drug Therapy by Countries
9.1 Middle East and Africa Diabetes Drug Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Diabetes Drug Therapy Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Diabetes Drug Therapy Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9.3 UAE Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9.4 Egypt Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9.5 Nigeria Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
9.6 South Africa Diabetes Drug Therapy Sales and Growth Rate (2013-2018)
10 Global Diabetes Drug Therapy Market Segment by Type
10.1 Global Diabetes Drug Therapy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Diabetes Drug Therapy Sales and Market Share by Type (2013-2018)
10.1.2 Global Diabetes Drug Therapy Revenue and Market Share by Type (2013-2018)
10.2 Glucagon-like peptide-1 (GLP-1) agonist Sales Growth and Price
10.2.1 Global Glucagon-like peptide-1 (GLP-1) agonist Sales Growth (2013-2018)
10.2.2 Global Glucagon-like peptide-1 (GLP-1) agonist Price (2013-2018)
10.3 Dipeptidyl-peptidase-4 (DPP-4) inhibitors Sales Growth and Price
10.3.1 Global Dipeptidyl-peptidase-4 (DPP-4) inhibitors Sales Growth (2013-2018)
10.3.2 Global Dipeptidyl-peptidase-4 (DPP-4) inhibitors Price (2013-2018)
10.4 Sodium glucose co-transporter 2 (SGLT2) inhibitors Sales Growth and Price
10.4.1 Global Sodium glucose co-transporter 2 (SGLT2) inhibitors Sales Growth (2013-2018)
10.4.2 Global Sodium glucose co-transporter 2 (SGLT2) inhibitors Price (2013-2018)
10.5 Insulin Sales Growth and Price
10.5.1 Global Insulin Sales Growth (2013-2018)
10.5.2 Global Insulin Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Diabetes Drug Therapy Market Segment by Application
11.1 Global Diabetes Drug Therapy Sales Market Share by Application (2013-2018)
11.2 Type 1 Diabetes Sales Growth (2013-2018)
11.3 Type 2 Diabetes Sales Growth (2013-2018)
11.4 Gestational Diabetes Sales Growth (2013-2018)
11.5 Impaired Glucose Tolerance and Impaired Fasting Glycaemia Sales Growth (2013-2018)
12 Diabetes Drug Therapy Market Forecast (2018-2023)
12.1 Global Diabetes Drug Therapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Diabetes Drug Therapy Market Forecast by Regions (2018-2023)
12.2.1 North America Diabetes Drug Therapy Market Forecast (2018-2023)
12.2.2 Europe Diabetes Drug Therapy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Diabetes Drug Therapy Market Forecast (2018-2023)
12.2.4 South America Diabetes Drug Therapy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Diabetes Drug Therapy Market Forecast (2018-2023)
12.3 Diabetes Drug Therapy Market Forecast by Type (2018-2023)
12.3.1 Global Diabetes Drug Therapy Sales Forecast by Type (2018-2023)
12.3.2 Global Diabetes Drug Therapy Market Share Forecast by Type (2018-2023)
12.4 Diabetes Drug Therapy Market Forecast by Application (2018-2023)
12.4.1 Global Diabetes Drug Therapy Sales Forecast by Application (2018-2023)
12.4.2 Global Diabetes Drug Therapy Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Diabetes Drug Therapy Picture
Table Product Specifications of Diabetes Drug Therapy
Figure Global Sales Market Share of Diabetes Drug Therapy by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
